{"organizations": [], "uuid": "ddc3fed4140c146bde79ebd9e5172199d97ef512", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-ablynxs-board-says-takeover-propos/brief-ablynxs-board-says-takeover-proposal-from-novo-nordisk-undervalues-company-idUSASM000HTR", "country": "US", "domain_rank": 408, "title": "BRIEF-Ablynx's Board Says Takeover Proposal From Novo Nordisk Undervalues Company", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-08T20:43:00.000+02:00", "replies_count": 0, "uuid": "ddc3fed4140c146bde79ebd9e5172199d97ef512"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-ablynxs-board-says-takeover-propos/brief-ablynxs-board-says-takeover-proposal-from-novo-nordisk-undervalues-company-idUSASM000HTR", "ord_in_thread": 0, "title": "BRIEF-Ablynx's Board Says Takeover Proposal From Novo Nordisk Undervalues Company", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "board says takeover proposal from novo nordisk undervalues company", "sentiment": "negative"}, {"name": "j.p. morgan", "sentiment": "none"}, {"name": "novo nordisk", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - ABLYNX NV:\n* BOARD UNANIMOUSLY CONCLUDED THAT PROPOSAL FUNDAMENTALLY UNDERVALUES ABLYNX AND ITS STRONG PROSPECTS FOR CONTINUED GROWTH AND VALUE CREATION\n* TODAY CONFIRMED THAT ON DEC 22, 2017 IT RECEIVED UNSOLICITED CONDITIONAL PROPOSAL FROM NOVO NORDISK A/S\n* J.P. MORGAN IS SERVING AS FINANCIAL ADVISOR TO ABLYNX * ABLYNX STRONGLY BELIEVES UNSOLICITED CONDITIONAL PROPOSAL FROM NOVO NORDISK FUNDAMENTALLY UNDERVALUES THE COMPANY AND ITS FUTURE PROSPECTS\n* CO LONG-TERM STRATEGIC PLAN OF BECOMING FULLY INTEGRATED BIOPHARMACEUTICAL COMPANY\n* “BOARD SEES NO MERIT IN CEDING CONTROL OF ITS ASSETS WITHOUT FULL UPFRONT VALUE RECOGNITION FOR SHAREHOLDERS” - CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T20:43:00.000+02:00", "crawled": "2018-01-09T16:49:22.000+02:00", "highlightTitle": ""}